Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.35 |
| ▸ | PPARG | P37231 | 5/20 | 0.35 |
| ▸ | RARG | P13631 | 3/20 | 0.35 |
| ▸ | HMGCR | P04035 | 2/20 | 0.35 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5664303 | 0.90 | RXRA (0.35) | RXRAPPARGRARGHMGCRTNFRSF1A | |
| SCHEMBL5667118 | 0.90 | RXRA (0.35) | RXRAPPARGRARGHMGCRTNFRSF1A | |
| SCHEMBL5671320 | 0.88 | HMGCR (0.40) | RXRAPPARGRARGHMGCRNR1I2 | |
| SCHEMBL5663755 | 0.87 | RXRA (0.36) | RXRAPPARGRARGHMGCRTNFRSF1A | |
| SCHEMBL5668478 | 0.83 | RARG (0.39) | RXRAPPARGRARGTNFRSF1A | |
| SCHEMBL6671237 | 0.82 | RXRA (0.34) | RXRAPPARGRARGHMGCRTNFRSF1A | |
| SCHEMBL5669988 | 0.80 | HMGCR (0.49) | RXRAHMGCRNR1I2L3MBTL1 | |
| SCHEMBL5665321 | 0.78 | HMGCR (0.38) | RXRAPPARGRARGHMGCRNR1I2 | |
| SCHEMBL5663808 | 0.78 | HMGCR (0.38) | RXRAPPARGRARGHMGCRNR1I2 | |
| SCHEMBL6686592 | 0.78 | HMGCR (0.36) | RXRAPPARGRARGHMGCRTNFRSF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004026242-A2 | SUBSTITUTED KETOPHOSPHONATE INHIBITORS OF TUMOR CELL PROLIFERATION | ILEX ONCOLOGY RESEARCH, SARL (CH) | 2004-04-01 | — | — | WO | disclosed |